HYBRID EVENT: You can participate in person at Boston, Massachusetts, USA or Virtually from your home or work.

2nd Edition of International Congress on Clinical Immunology and Allergy

October 23-25, 2023 | Hybrid Event

About ICIA 2023 | Hybrid Event

Magnus Group is ecstatic to announce and welcome you to its 2nd Edition of International Congress on Clinical Immunology and Allergy” (ICIA 2023) which is going to be held in hybrid format during October 23-25, 2023 in Boston, Massachusetts, USA.

The global summit will be focused on the theme “ Understanding Allergies and Boosting Immunity through Novel Research.

ICIA 2023 is the finest place to expand one's scientific knowledge by sharing it through oral and poster presentations and to form a strong network with eminent people, key decision makers from academic institutions, healthcare institutes, immunological societies, the vaccine industry, and biotech organizations from all over the world.

The conference intends to instill a strong belief that by integrating immunology and its characteristics with other health and medical sciences, all other health and medical sciences can provide healthy circumstances. There are numerous opportunities to get involved with the researchers, scientists, clinicians, academicians, biotechnologists, pharmacists, immunologists, allergy specialists, industry delegates, and individuals sharing an interest in immunology to contribute to the goal of promoting and supporting excellence in immunology research, and clinical practice for the benefit of animal and human health and welfare. Plenary talks, symposia, keynote sessions, as well as several collaborative events will “open doors” to develop professional bonds with related societies.

We sincerely hope you will join us at ICIA 2023 “opening doors to the world of clinical immunology and allergies” and welcome colleagues from all over the world by assisting us in bringing the premier event for the global community to fruition, making it your go-to meeting in 2023.

Recommended Conferences: Immunology Conferences 2023 | Clinical Immunology Conferences | Allergy Conferences 2023 | Microbiology Conferences 2023 | Clinical Microbiology Meetings 2023 | Infectious Diseases Events

Scientific Sessions

  • Allergy and Immunology
  • Antigen Research
  • Auto-Inflammation and Autoimmunity
  • Contagious Diseases and Immunology
  • Microbial Immunology and Molecular Immunology
  • Clinical Immunology and Laboratory Immunology
  • Computational Immunology
  • Diagnostic Immunology
  • HIV Immunology
  • Immunoassays
  • Immune Pathology and Pharmacology
  • Immunodeficiency Diseases and Disorders
  • Immunodermatology
  • Immunogenetics
  • Immunometabolism
  • Immunotoxicology
  • Immunohematology
  • Immunology of Barrier Surfaces

Scientific Committee Members

Speaker at Clinical Immunology and Allergy 2023 - Ranjan Ramasamy

Ranjan Ramasamy

IDFISH Technology, United States
Speaker at Clinical Immunology and Allergy 2023 - Zhaohua Zhou

Zhaohua Zhou

Food and Drug Administration, United States
Speaker at Clinical Immunology and Allergy 2023 - Roque Gabriel Wiseman Pinto

Roque Gabriel Wiseman Pinto

Medical College,Bambolim, India
Speaker at Clinical Immunology and Allergy 2023 - Luca Roncati

Luca Roncati

University of Modena and Reggio Emilia, Italy

Earlybird Registrations Closes on January 31st 2023

register

Media Partner

Kind Congress
Conference Locate
What is Research
Yellmed
Placidway
The Pharma Times
Course for Doctors
Medical Events Guide
Tabeeby
Health and Medical Tourism
World Conference Alert
Conference Alert

Past Conference Information

Upcoming Immunology Conference:

Conference Name Dates  Venue
2nd Edition of International Congress on Clinical Immunology and Allergy October 23-25, 2023 Boston | USA

Magnus Group is pleased to announce its “International Conference on Clinical Immunology and Allergy” (ICIA 2022) which is all set to take place during October 19 -20, 2022.

During the International Conference, thousands of pulmonary specialists, researchers, scientists, professors, healthcare professionals and giant industry spokesperson will gather in order to learn about and present the most recent developments in the rapidly expanding field of Clinical immunology.

For ICIA 2022 Program: Click Here
For ICIA 2022 Abstract Book: Click Here

Upcoming Immunology ConferencesImmunology Conferences 2023 | Clinical Immunology Conferences | Allergy Conferences 2023 | Clinical Immunology Events | Global Conference on Clinical Immunology 2023 | International Conference on Allergy | Clinical Immunology Congress | Clinical Immunology Events | Clinical Immunology Meetings 2023 | Clinical Immunology Conference | Allergy Congress 2023 | Allergy Conference 2023 | Immunology MeetingImmunology Conference 2023 | Global Conference on Allergy 2023

Day 1
Keynote Presentations

Ranjan Ramasamy, IDFISH Technology, United States
Title: Genetic factors influencing early immunity to SARS-CoV-2 in the upper respiratory tract

WenQing Yang, Simcere Pharma Group, China
Title: Considerations on MS animal modeling: Format of myelin immunogens used for experimental autoimmune encephalomyelitis model establishment may affect pharmacologic responses of anti-inflammatory drugs

Ismail Osmanov, Children's City Clinical Hospital, Russian Federation
Title: Monoclonal antibodies efficacy in treatment of novel coronavirus infection (COVID-19) in children at risk of developing a severe course of the disease

Oral Presentations:
Xuexiang Du, Shandong University School of Basic Medical Sciences, China Title: Safe and effective immunotherapy by targeting CTLA-4

Presenter 1: WenQing Yang, Simcere Pharma Group, China
Presenter 2: Liting Xue, Simcere Pharma Group, China
Title: Generation and application of humanized mouse tumor models to expedite translational research for Immuno-Oncology

Matthias Hardtke Wolenski, Hannover Medical School, Germany
Title: Regulatory T cells with chimeric antigen receptors as treatment for autoimmunity

Roque Gabriel Wiseman Pinto, Medical College, Bambolim, India
Title: Rise in allergies in Goa post COVID – 19

Bushra Akhtar, University of Agriculture, Pakistan
Title: Methotrexate nanoparticles ameliorate Freund’s complete adjuvant induced arthritis in Wistar rats

Maliheh Amani, Gonabad University of Medical Sciences, Iran (Islamic Republic of)
Title: Differentiation discoid lupus erythematosus associated-scaring alopecia from lichen planopilaris by immunostaining of CD123 marker

Esin Kirikkaya, Health Sciences University İzmir Tepecik Training And Research Hospital, Turkey
Title: The effect of subcutaneous omalizumab therapy on the allergic conjunctivitis symptoms of patients being treated for asthma

Luca Roncati, University of Modena and Reggio Emilia, Italy
Title: Autoptic findings in VITT (Vaccine-induced Immune Thrombotic Thrombocytopenia alias Vaccine Induced Thrombosis with/without Thrombocytopenia)

Amal Saad Hussein, Environment & Climate Change Research Institute, National Research Centre, Egypt
Title: Immunological disorders due to occupational exposures

Emmanuel Ifeanyi Obeagu, Kampala International University, Uganda
Title: An update on childhood immunisation: Africa perspective

Juan Huang, Yale University, United States
Title: Altered systemic and intestinal IgA immune responses in individuals with type 1 diabetes

Marina Awad Zaher, Beni-Suef University, Egypt
Title: Cardiac and vascular dysfunction in patients with multiple sclerosis

Poster Presentations:
Alec Bigness, University of South Florida Morsani College Of Medicine, United States
Title: Kaposi Sarcoma Associated Immune Reconstitution Inflammatory Syndrome (Ks-Iris) – Recognition and treatment in the age of advancing antiretroviral therapy

Laura Elisa Buitrago Molina, Hannover Medical School, Germany
Title: Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis

Jamil M. A. S. Obaid, Ibb University, Yemen
Title: Comparison between virulent genes-based and serotype-based vaccine for uropathogenic escherichia coli

Alex Zhu, University of Duisburg-Essen, United States
Title: Robust antibody-mediated protection against SARS-CoV-2 induced by NVXCoV2373 subunit vaccine adjuvanted with matrix-M

Keynote presentations:
Zhaohua Zhou, Food And Drug Administration, United States
Title: Mast cell degranulation links anti-PEG IgE to anaphylaxis caused by PEGylated drugs and PEG-contained LNP/mRNA COVID vaccines

Mayra Ramos Suzarte, Center of Molecular Immunology, Cuba
Title: Therapeutic repositioning of the monoclonal antibodies itolizumab and nimotuzumab in COVID-19

Oral presentations:
Miceska Simona, Institute of Oncology Ljubljana, Slovenia
Title: Cytopathological assessment is an accurate method for identifying immunophenotypic features and BRCA1/2 mutations of high-grade serous carcinoma from ascites

Gulinnaz Ercan, Ege University, Turkey
Title: The crucial role of stem cells in NK cell production and enhancement of NK cell activity in Pancreas Cancer

Upcoming Immunology ConferencesImmunology Conferences 2023 | Clinical Immunology Conferences | Allergy Conferences 2023 | Clinical Immunology Events | Global Conference on Clinical Immunology 2023 | International Conference on Allergy | Clinical Immunology Congress | Clinical Immunology Events | Clinical Immunology Meetings 2023 | Clinical Immunology Conference | Allergy Congress 2023 | Allergy Conference 2023 | Immunology MeetingImmunology Conference 2023 | Global Conference on Allergy 2023

Day 02
Keynote presentations
:
Vincenzo Alfano, University of Messina, Italy
Title: Your vaccine attitude determines your altitude what are the determinants of attitude toward vaccination?

Sudhakar Bangera, MBBS, MD, MMedSc, Fellow-Vaccinology Managing Partner AILEEN Clinical Research Services AILEEN, India
Title: The need for separate regulations for prophylactic vaccines

Rosane Cuber Guimaraes, Bio-Manguinhos/ Fiocruz, Brazil
Title: Analytical transfer of COVID-19 recombinant vaccine between fiocruz and astrazeneca

Oral presentations:
Deborah Hilton, Deborah Hilton Statistics Online, Australia
Title: Global COVID-19 vaccine policies – A literature review

Yusuke Oji, Osaka University Graduate School of Medicine, Japan
Title: IgG and IgM antibody markers for immune monitoring in therapeutic cancer vaccine

Huixing Lin, Nanjing Agricultural University, China
Title: The potential application of recombinant swinepox virus expressing protective antigens of ASFV

Amarjeet Gambhir, Lady Hardinge Medical College & Associated Hospitals, India
Title: COVID-19 & mucormycosis

Lissete Sanchez Magraner, Hawk Biosystems, Spain
Title: PD-1/PD-L1 interaction is a predictive biomarker to stratify NSCLC lung cancer patients to immunotherapy

Vasiliki Georgakopoulou, Medical School of National and Kapodistrian University of Athens, Greece
Title: Factors predicting poor outcomes of patients treated with tocilizumab for COVID-19 pneumonia: A retrospective study

Satyabrata Dandapat, ICAR-Indian Veterinary Research Institute, India
Title: Strategic efforts towards development of a cell culture attenuated duck plague vaccine using an Indian virulent field isolate

Laleh Yazdanpanah Goharrizi, Agricultural Research Education and Extension Organization, Iran (Islamic Republic of)
Title: New technologies in shrimp and other crustacean vaccines

Muhammad Naveed Anwar, Chinese Academy of Agricultural Sciences, Pakistan
Title: Characterization of attenuated genotype 1 strain of Japanese encephalitis virus

Seyedeh Sajedeh Mousavi, Islamic Azad University, Iran (Islamic Republic of)
Title: Introducing the recent developments in the production of various COVID-19 vaccines in Iran

Mohammad Jalil Zorriehzahra, Iranian Fisheries Science Research Institute, Iran
Title: New developments in the field of aquatics vaccination in Iran and the world

Mohammad Zoladl, Yasuj University of Medical Sciences, Iran
Title: The involvement of the nurses in vaccination process: History, advantages, limitations, challenges, and perspective of their role in the future

Julia Bespyatykh, Federal Research and Clinical Centre of Physical-Chemical Medicine, Russian Federation
Title: Immune responses to inactivated vaccine against COVID-19 (CoviVac) in adults’ individuals

Mina Ziarati, Islamic Azad University, Iran (Islamic Republic of)
Title: Introducing the latest new findings regarding COVID-19 vaccine in Iran and the world

Vasiliki Georgakopoulou, Medical School of National and Kapodistrian University of Athens, Greece
Title: Onodera’s prognostic nutritional index: Comparison of its role in severity and outcomes of COVID-19 patients among the periods of alpha, delta and omicron variant predominance

Joseph Anejo-Okopi, Federal University of Health Sciences Otukpo, Nigeria
Title: Lassa fever virus vaccine: Where are we?

Angelo Tunin Chica Pergo, Faculty of Medicine of Itajuba, Brazil
Title: Development and validation of a specific tool to assess vaccination hesitation during the COVID-19 pandemic

Christine Bricault, Sanofi Vaccines, United States
Title: Characterization of prefusion-F-specific antibodies elicited by natural infection with human metapneumovirus from two older adults

Solange Whegang Youdom, University of Dschang, Cameroon
Title: Missed opportunities for vaccination and associated factors among children aged 12-23 months in Cameroon

Sissy Therese Sonnleitner, Innsbruck Medical University, Austria
Title: Studies on the evolution of a SARS-CoV-2 variant of concern – The story of immune escape in an immunocompromised patient

We thank all our participants for joining and making the event sucessfull.

Upcoming Immunology ConferencesImmunology Conferences 2023 | Clinical Immunology Conferences | Allergy Conferences 2023 | Clinical Immunology Events | Global Conference on Clinical Immunology 2023 | International Conference on Allergy | Clinical Immunology Congress | Clinical Immunology Events | Clinical Immunology Meetings 2023 | Clinical Immunology Conference | Allergy Congress 2023 | Allergy Conference 2023 | Immunology MeetingImmunology Conference 2023 | Global Conference on Allergy 2023

Upcoming Immunology Conference
Conference Name: 2nd Edition of International Congress on Clinical Immunology and Allergy
Dates: October 23-25, 2023
Venue: Boston, Massachusetts, USA

For Magnus Group Conferences Reviews:
Magnus Group Immunology Conferences Reviews | Magnus Conferences Reviews

Conference Schedule

08:00-09:00

Registration

09:00-09:30

Opening Ceremony and Introduction

09:30-10:30

Keynote Session I

10:30-11:00

Refreshment Break

11:00-12:30

Keynote Session II

12:30-13:30

Lunch

13:30-15:00

Break Out Session I

15:00-15:30

Refreshment Break

15:30-18:00

Break Out Session II

09:00-10:30

Keynote Session III

10:30-11:00

Refreshment Break

11:00-12:30

Break Out Session III

12:30-13:30

Lunch

13:30 15:00

Poster Presentations

15:00-15:30

Refreshment Break

15:30-18:00

Break Out Session IV

09:00-10:30

Keynote Session IV

10:30-11:00

Refreshment Break

11:00-12:30

Break Out Session V

12:30-13:30

Lunch

13:30 15:00

Break Out Session VI

15:00-15:30

End Note Session and Closing Ceremony

Watch Past Conference Reviews

Photo Gallery (Our Past Events)

Testimonials

Watsapp